InsidersTradesSigma
Follow the CANDEL THERAPEUTICS INC stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1bn. The latest transaction was reported on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: SESHU P TYAGARAJAN. Every trade is accessible without an account.
Analysts rate CANDEL THERAPEUTICS INC Strong Buy (bullish), based on 8 analysts. Average price target: US$21.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
CANDEL THERAPEUTICS INC 是一家专注于开发治疗严重疾病的创新疗法的公司。该公司在纳斯达克上市，股票代码为 XNAS。